CHE - Chemed Corporation
| Previous Close | 429.94 |
| Open | 433.49 |
| Bid | 432.06 x 800 |
| Ask | 432.86 x 800 |
| Day's Range | 431.05 - 433.45 |
| 52 Week Range | 260.03 - 433.98 |
| Volume | 38,563 |
| Avg. Volume | 111,511 |
| Market Cap | 6.896B |
| Beta (3Y Monthly) | 0.87 |
| PE Ratio (TTM) | 35.81 |
| EPS (TTM) | 12.10 |
| Earnings Date | Oct 28, 2019 - Nov 1, 2019 |
| Forward Dividend & Yield | 1.28 (0.30%) |
| Ex-Dividend Date | 2019-08-09 |
| 1y Target Est | 440.00 |
- Zacks
Outlook for Outpatient and Home Healthcare Industry Looks Bright
Outlook for Outpatient and Home Healthcare Industry Looks Bright
- Zacks
The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita
The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita
- Zacks
DVA or CHE: Which Is the Better Value Stock Right Now?
DVA vs. CHE: Which Stock Is the Better Value Option?
- Zacks
5 Safe Picks Amid Yield Inversion and Geopolitical Concerns
Throughout this month, U.S. stock markets are witnessing extreme volatility. Equities are suffering as investors are flocking to safe-haven sovereign bonds.
- GuruFocus.com
Chemed Corp (CHE) executive vice president & CFO David Patrick Williams Sold $7. ...
executive vice president & CFO of Chemed Corp (30-Year Financial, Insider Trades) David Patrick Williams (insider trades) sold 17,979 shares of CHE on 08/12/2019 at an average price of $430.8 a share. Continue reading...
- Simply Wall St.
Chemed (NYSE:CHE) Seems To Use Debt Rather Sparingly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
- GuruFocus.com
Chemed Corp (CHE) president and CEO Kevin J Mcnamara Sold $5 million of Shares
president and CEO of Chemed Corp (30-Year Financial, Insider Trades) Kevin J Mcnamara (insider trades) sold 12,000 shares of CHE on 08/07/2019 at an average price of $416.8 a share. Continue reading...
- Zacks
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes "
Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Business Wire
Chemed Corporation Releases Updated Guidance
The VITAS and Chemed updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS on July 31, 2019, and effective October 1, 2019. This updated guidance also includes certain increased costs related to revenue pass-through under certain inpatient unit agreements.
- Business Wire
Roto-Rooter To Buy Assets of Its Largest Independent Franchise Operator
Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation announced it has entered into an agreement to acquire all of HSW RR, Inc.’s franchise operations and Western Drain Supply for an aggregate purchase price of $120 million.
- Business Wire
Chemed Corporation Declares Quarterly Dividend of 32 Cents
Chemed Corporation (CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 32-cents per share on the Company’s capital stock, payable on September 3, 2019, to shareholders of record as of August 12, 2019. The previous dividend increase was in August 2018, when the Board raised the quarterly dividend from 28-cents to 30-cents per share. This represents the 193rd consecutive quarterly dividend paid by Chemed in its 48 years as a public company.
- Zacks
Buy These 5 Low Leverage Stocks to Keep Your Portfolio Secure
Since existence of a debt-free company is rare, the real challenge for an investor is determining whether an organization???s debt level is sustainable.
- Thomson Reuters StreetEvents
Edited Transcript of CHE earnings conference call or presentation 26-Jul-19 2:00pm GMT
Q2 2019 Chemed Corp Earnings Call
- Zacks
Chemed (CHE) is a Great Momentum Stock: Should You Buy?
Does Chemed (CHE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Motley FoolChemed Corp (CHE) Q2 2019 Earnings Call Transcript
CHE earnings call for the period ending June 30, 2019.
- Zacks
Chemed (CHE) Earnings Top Estimates in Q2, Margins Expand
It is encouraging to note that Chemed (CHE) witnessed solid revenue growth across both of its key subsidiaries.
- Zacks
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of 8.74% and 0.80%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Chemed Reports Second-Quarter 2019 Results
Chemed Corporation , which operates VITAS Healthcare Corporation , one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation
- Zacks
DVA vs. CHE: Which Stock Is the Better Value Option?
DVA vs. CHE: Which Stock Is the Better Value Option?
- Simply Wall St.
Is Chemed Corporation's (NYSE:CHE) 35% ROE Better Than Average?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Zacks
Chemed (CHE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak
Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.
- Zacks
Here's Why Chemed (CHE) Should Remain in Your Portfolio Now
Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.
- Simply Wall St.
Here's What Chemed Corporation's (NYSE:CHE) P/E Is Telling Us
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
